Overview

Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to explore the neurocognitive efficacy of Sertindole versus comparator in patients with schizophrenia using the MCCB.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Quetiapine Fumarate
Sertindole